Replies

There was an article about a month ago about injections of T-cells into the Cochlea to regrow the tiny hairs.

From BRAVE AI:

Cochlear T-Cell Hair Regrowth
Injections of T-cells into the cochlea to regrow tiny hairs, also known as hair cells, are still an experimental approach and not a widely established treatment for hearing loss. The mammalian cochlea, including humans, has limited regenerative potential, and adult hair cells do not regenerate after damage.

Notable Research

Some studies have explored the use of stem cells or progenitor cells to regenerate hair cells. For example, Frequency Therapeutics, a MIT spinout, is developing a small molecule-based regenerative therapy that targets progenitor cells to create hair cells of the inner ear and reverse hearing loss. This approach involves injecting small molecules into the ear to stimulate the growth of hair cells.

Challenges and Limitations

Intratympanic injections, which deliver compounds directly into the middle ear, have a risk of low yield and may not effectively reach the cochlea. Intracochlear injections carry risks of infection and increased cochlear trauma. Systemic (IV) delivery has systemic side effects. The optimal route of delivery from a therapeutic perspective is still unknown.

Clinical Trials and Future Directions

While there are ongoing clinical trials modulating the Wnt and/or Notch pathways with novel compounds, the search results do not specifically mention T-cell injections into the cochlea for hair cell regeneration. Future research may focus on refining delivery methods and optimizing treatment protocols to effectively stimulate hair cell regeneration.

Patient Involvement

Patients with hearing loss and tinnitus are eager to participate in clinical trials and potential future studies on hair cell regeneration. However, it is essential to note that the current understanding of T-cell injections into the cochlea for hair cell regeneration is still in its experimental stages, and no established treatments or clinical trials exist for this specific approach.

Conclusion

Injections of T-cells into the cochlea to regrow tiny hairs are an area of ongoing research, but not a widely established treatment for hearing loss. While some studies explore stem cell-based approaches, the optimal route of delivery and treatment protocols remain uncertain. Patients with hearing loss and tinnitus should be aware of ongoing and future clinical trials, but it is crucial to prioritize evidence-based treatments and avoid unproven or experimental approaches.